Lauren Anto, PA
Medical · Bethany, OKNPI 1316420086
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,724 of the $5,052 with a category attached, or 73.7%. 29 manufacturers reported payments, led by Biohaven Pharmaceutical Holding Company Ltd. at 31.1% of the total. Reporting peaked in 2022 at $2,612 and has fallen 95.3% since, to $124 in 2025.
Across 265 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- AbbVie$848
- Lilly USA, LLC$555
- Amgen$361
- AstraZeneca$267
- Clarus Therapeutics Inc.$201
- plus $1K from 23 others
What the payments were for
- Consulting fees$80016%
- Travel & lodging$52810%
- Food & beverage$3,72474%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $1,572 |
| AbbVie | 83 | $848 |
| Lilly USA, LLC | 37 | $555 |
| Amgen | 23 | $361 |
| AstraZeneca | 18 | $267 |
| Clarus Therapeutics Inc. | 13 | $201 |
| GSK | 11 | $171 |
| Biohaven Pharmaceuticals, Inc. | 14 | $149 |
| Novo Nordisk | 9 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $116 |
| Antares Pharma, Inc. | 6 | $112 |
| Pfizer | 5 | $83 |
| Medtronic | 4 | $80 |
| Boehringer Ingelheim | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Impel Pharmaceuticals Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Johnson & Johnson | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Phadia US Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $19 |
| Kaleo, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Merck | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $11 |
| Corium, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,328
How this compares
$5,052 in reported general payments places this provider in the 85th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $700 |
| Omeprazole | 12 | $348 |
| Olmesartan Medoxomil | 12 | $308 |
| Montelukast Sodium | 12 | $237 |
| Atorvastatin Calcium | 16 | $147 |
| Levothyroxine Sodium | 15 | $137 |
| Rosuvastatin Calcium | 12 | $118 |
| Meloxicam | 11 | $82 |
| Cyclobenzaprine Hcl | 11 | $79 |
| Amlodipine Besylate | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other medical in Bethany
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
- Katelyn PuryearOklahoma City$22K
- Tara LinvilleTulsa$19K
- Debra OdomTulsa$17K
- Donna BowersTuttle$16K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.